Quellen (Literatur auf Anfrage erhältlich bei Lundbeck):
14 Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014 Oct;94(4):1099-142.
19 Durham PL. CGRP-receptor antagonists – a fresh approach to migraine therapy? N Engl J Med. 2004 Mar 11;350(11):1073-5.
21 Diener HC et al. Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: subgroup analysis of PROMISE-2. Headache. 2021;61(1):125–36.
14 Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014 Oct;94(4):1099-142.
19 Durham PL. CGRP-receptor antagonists – a fresh approach to migraine therapy? N Engl J Med. 2004 Mar 11;350(11):1073-5.
21 Diener HC et al. Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: subgroup analysis of PROMISE-2. Headache. 2021;61(1):125–36.